On August 28, 2023, Baird analyst Joel Beatty expressed his confidence in Immutep (NASDAQ:IMMP) by reiterating an “Outperform” rating and maintaining a price target of $7. This forecast indicates a significant growth potential for the stock, considering its current share price of $2.11. Notably, other stock analysts also share a positive outlook on Immutep, with an average 12-month stock price projection of $8.50, suggesting a potential increase of 349.74%. It is crucial to acknowledge that these forecasts and targets are based on the opinions of analysts and prevailing market trends, and the actual performance of the stock may deviate from these predictions.
https://beststocks.com/positive-outlook-for-immutep-nasdaq-immp-with/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.